News
Sarepta said it accepts the CHMP decision on Elevidys, while partner Roche said it will continue working with the EMA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback